Bayewitz Ashrei, Scorziello Barbara, Maala Clarice, Giannattasio Emily, Billett Henny Heisler
Department of Medicine, Winthrop-University Hospital, Mineola, NY, USA.
Int J Hematol. 2015 Mar;101(3):264-7. doi: 10.1007/s12185-015-1744-x. Epub 2015 Jan 31.
We investigated a bridging protocol using oral Vitamin K three days before scheduled surgery. 60 patients in two bridging protocols, 30 cases per protocol. The first cohort (Control group) had its warfarin held on Day-5 (five days before surgery). The intervention cohort (Vitamin K group) routinely received 2.5 mg of oral Vitamin K on Day-3 but was otherwise identically bridged. Primary outcome was INR on Day-1. Secondary outcomes included patients with INRs ≥1.5 on Day-1, bleeding episodes and elevated INR post surgery. Day-1 INR for the Vitamin K group was 1.16, vs. 1.28 for the Control group (p = 0.037). Postoperative INR was similar. Only the Control group had patients with INRs ≥1.5 on Day-1, or patients with significant bleeding. Adding Vitamin K on Day-3 leads to a safe preoperative INR and may limit other complications.
我们研究了一种在预定手术前三天使用口服维生素K的桥接方案。60名患者分为两个桥接方案组,每组30例。第一组(对照组)在术前第5天(手术前五天)停用华法林。干预组(维生素K组)在术前第3天常规接受2.5mg口服维生素K,其他桥接措施相同。主要结局指标是术后第1天的国际标准化比值(INR)。次要结局指标包括术后第1天INR≥1.5的患者、出血事件以及术后INR升高情况。维生素K组术后第1天的INR为1.16,而对照组为1.28(p = 0.037)。术后INR相似。只有对照组有术后第1天INR≥1.5的患者或有明显出血的患者。在术前第3天添加维生素K可使术前INR安全,并可能减少其他并发症。